5N PLUS Net Income Over Time
| EMB Stock | EUR 17.10 0.08 0.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out 5N PLUS Performance and 5N PLUS Correlation. EMB |
Cross Equities Net Income Analysis
Compare 5N PLUS and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 477 M | 2.4 B | 3.7 B | 4.5 B | 7.1 B | 6.9 B | 5.7 B | 13.4 B | 15.4 B | 16.2 B |
| DAP | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.6 B | 2.5 B | 2.7 B | 3 B | 3.6 B | 6.4 B | 7.2 B | 4.8 B | 3.9 B | 4.5 B | 4.5 B |
| 6MK | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 2.4 B | 6.2 B | 9.8 B | 7.1 B | 13 B | 14.5 B | 365 M | 17.1 B | 19.7 B | 20.7 B |
| AMD | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | (497 M) | 43 M | 337 M | 341 M | 2.5 B | 3.2 B | 1.3 B | 854 M | 1.6 B | 4.3 B | 4.6 B |
| 4I1 | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 7 B | 6 B | 7.9 B | 7.2 B | 8.1 B | 9.1 B | 9 B | 7.8 B | 7.1 B | 11.3 B | 8.9 B |
| W8V | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 164.6 B | 172.4 B | 180.1 B | 187.4 B | 192.9 B | 216.6 B | 226.5 B | 231.9 B | 237.8 B | 273.5 B | 221.2 B |
| TOTB | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 6.2 B | 8.6 B | 11.4 B | 11.3 B | (7.2 B) | 16 B | 20.5 B | 21.4 B | 15.8 B | 18.1 B | 12.7 B |
| AMG | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 7.7 B | 2 B | 8.4 B | 7.8 B | 7.3 B | 5.9 B | 6.6 B | 6.7 B | 4.1 B | 7.7 B | 7.1 B |
| HBC1 | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 13.7 B | 13.5 B | 2.5 B | 10.8 B | 13.7 B | 7.4 B | 5.2 B | 13.9 B | 15.6 B | 23.5 B | 24 B | 27.6 B | 14.7 B |
| HK2C | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 5.8 B | 7.4 B | 9.3 B | 9.4 B | 11.5 B | 12.5 B | 10.1 B | 11.9 B | 13.1 B | 15 B | 11.1 B |
5N PLUS and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in 5N PLUS financial statement analysis. It represents the amount of money remaining after all of 5N PLUS operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| 5N PLUS | EMB |
Specialization | Basic Materials, Specialty Chemicals |
| Business Address | 4385, Garand Street, |
| Exchange | Frankfurt Exchange |
EUR 17.1
Other Information on Investing in EMB Stock
5N PLUS financial ratios help investors to determine whether EMB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMB with respect to the benefits of owning 5N PLUS security.